The Chemotherapy Adjuvant Study for women with advanced Age (CASA) trial studied elderly women aged ≥65 years with endocrine non-responsive (ER and PR negative) breast cancer who were not suitable to receive standard chemotherapy regimen [42]. The gene discussed is ESR1; the disease is breast cancer.